{"denomUnitsSelected":"Participants","description":"Pharmacokinetic concentrations of daratumumab","reportingStatus":"NOT_POSTED","timeFrame":"From randomization to the clinical cutoff date. Maximum follow up was 54.41 months","title":"Pharmacokinetic Concentrations of Daratumumab","type":"SECONDARY"}